Showing results (1541-1550 of 1,576) with videos related to

Sort By:
Pageof 158
Journal of Thrombosis and Haemostasis : JTH|November 6, 2024
Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolismBehnood Bikdeli, Candrika D Khairani, Antoine Bejjani, et al.
Diabetes Care|June 4, 2025
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort StudyDaniel R Morales, Fan Bu, Benjamin Viernes, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 17, 2023
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort studyHiam Chemaitelly, Jeremy Samuel Faust, Harlan M Krumholz, et al.
Communications Medicine|May 9, 2025
Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVIDConnor B Grady, Bornali Bhattacharjee, Julio Silva, et al.
Nature Medicine|July 12, 2020
Extrapulmonary manifestations of COVID-19Aakriti Gupta, Mahesh V Madhavan, Kartik Sehgal, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVIDConnor B Grady, Bornali Bhattacharjee, Julio Silva, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Distinguishing features of Long COVID identified through immune profilingJon Klein, Jamie Wood, Jillian Jaycox, et al.
American Journal of Hypertension|March 8, 2022
Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control HypertensionYvonne Commodore-Mensah, Fleetwood Loustalot, Cheryl Dennison Himmelfarb, et al.
JAMA Network Open|March 24, 2022
Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational CohortYuan Lu, Mui Van Zandt, Yun Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2025
Comparative Safety of Second-Line Antihyperglycemic Agents in Older Adults with Type 2 Diabetes: A Multinational Real-World Evidence From LEGEND-T2DMChungsoo Kim, Fan Bu, Clair Blacketer, et al.
Pageof 158